S&P downgrades St. John’s Riverside Hospital’s rating 3 notches to ‘B-‘, maintains negative outlook

S&P Global Ratings downgraded Yonkers, N.Y.-based St. John’s Riverside Hospital’s rating three notches to “B-” from “BB-.”

Advertisement

The downgrade is a result of several factors, including St. John’s mounting operational challenges, multiyear operating losses, weak liquidity metrics, weak debt coverage and high leverage.

The outlook is negative, reflecting the hospital’s operating challenges.

In March, the hospital sought to partner with several major healthcare systems. S&P did not acknowledge the requests in its rating.

More articles on healthcare finance:
New Medicaid funding formula for Illinois hospitals wins federal OK: 4 things to know
Hospitals are moving to single ratings: Here’s why
Fitch: Minor headwinds coming for US children’s hospitals

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.